← All news
Markets
Rocket Lab's Sell-Off Is Fading—Is It Finally Safe to Buy?
2 outlets - including Yahoo and Marketbeat - are covering this story. Rocket Lab posted record Q2 revenue and backlog and keeps winning defense contracts, but shares remain volatile as investors await Neutron's fourth-quarter debut before re-rating the stock.
Covered by 2 outlets
All coverage · 2 articles
Yahoo Finance News
·Aug 23, 14:25 UTC
Rocket Lab's Sell-Off Is Fading—Is It Finally Safe to Buy?
MarketBeat
·Aug 23, 09:25 UTC
Rocket Lab's Sell-Off Is Fading—Is It Finally Safe to Buy?
Rocket Lab posted record Q2 revenue and backlog and keeps winning defense contracts, but shares remain volatile as investors await Neutron's fourth-quarter debut before re-rating the stock.